Ignyta Lands $6,000,000 Series B Financing
-
Feed Type
-
Link
http://www.venturedeal.com/Search/SearchResultTransactionDetail.aspx?TransactionId=f45a285a-3005-47b2-baaa-8a4e15318d27&Preview=1 -
Date
1/1/2013 -
Company Name
Ignyta -
Mailing Address
11575 Sorrento Valley Road San Diego, CA 92121 -
Company Description
Ignyta, Inc. is a scientifically driven biotechnology company catalyzing personalized medicine in autoimmune diseases. Our goals are to revolutionize the quality of biomarkers and tests available to rheumatologists and patients to help them make better informed, more individualized treatment decisions; and to identify truly novel autoimmune disease targets for biopharmaceutical companies to enable the development of precise therapies for patients worldwide. -
Website
http://www.ignyta.com -
Transaction Type
Venture Equity -
Transaction Amount
$6,000,000 -
Transaction Round
Series B -
Proceeds Purposes
The company plans to use proceeds of its current round in 2013 to begin clinical studies to confirm its molecular based assay for diagnosing RA at its earliest, most-treatable stages. -
M&A Terms
-
Venture Investor
City Hill Ventures -
Venture Investor
Colt Ventures -
Venture Investor
Undisclosed
